MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Pharma Marketing News' source. Thu, 18 Mar 2010 15:16:04 +0100 http://www.medworm.com/index.php?rid=3304816&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn92-article04.htm This article summarizes the results of a survey designed to answer the questions: Should the pharmaceutical industry adopt similar self-regulatory principles that were established by media and marketing trade associations to protect consumer privacy when employing behavioral targeting, Should pharma marketers use behavioral targeting at all?, If they do use it, when is it appropriate? (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=3304816 Thu, 25 Feb 2010 14:15:57 +0100 3304816 http://www.medworm.com/index.php?rid=3304812&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_92_UpFront.pdf It seems like every pharmaceutical marketer is waiting for guidance from the FDA before they do more online marketing and especially more social media marketing. It's like Waiting for Godot -- guidance may never come. What then? Or it could come. Then what? (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=3304812 Thu, 25 Feb 2010 14:15:57 +0100 3304812 http://www.medworm.com/index.php?rid=3304815&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn92-article03.htm This article reviews the Who, What, and Why of Pharma's Social Media Working Group (SMWG) based on a conversation with Mark Gaydos, Senior Director, U.S. Regulatory Affairs Marketed Products at sanofi-aventis, and Cynthia Phillips, Sr Dir Labeling and Promotional Compliance at Millennium Pharmaceuticals. Also covered is an analysis of comments the SMWG submitted to the FDA on how pharmaceutical companies should handle off-label and adverse event posts made on social media sites owned or sponsored by them. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=3304815 Thu, 25 Feb 2010 14:15:48 +0100 3304815 http://www.medworm.com/index.php?rid=3304814&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn92-article02.htm This article reviews MedTera's HC Professional "Life Long Learning" Platform -- branded integrated physician marketing solutions -- and presents a summary of research on how brand teams see the mix of marketing tactics changing over the next several years. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=3304814 Thu, 25 Feb 2010 14:15:04 +0100 3304814 http://www.medworm.com/index.php?rid=3304813&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn92-article01.htm This article summarizes a survey that asked respondents to evaluate several ways in which Twitter could be used to improve patient support. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=3304813 Thu, 25 Feb 2010 14:14:14 +0100 3304813 http://www.medworm.com/index.php?rid=3210490&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_91_UpFront.pdf Whenever someone refers to a pharmaceutical company as a "healthcare company" the hairs on the back of my neck (where I still have some hair) rise up. Are pharmaceutical companies healthcare companies? Should we replace "pharmaceutical marketing" with "healthcare communications?" (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=3210490 Wed, 27 Jan 2010 14:30:43 +0100 3210490 http://www.medworm.com/index.php?rid=3210493&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn91-article03.htm This article reviews the physician payment lists published by Lilly, Merck, and GSK. The analysis gives us more insight into the fees paid by various companies, how the money was distributed by state and region in the US, and what types of activities (eg, speaker fees vs. consulting fees) physicians were paid to perform. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=3210493 Wed, 27 Jan 2010 14:30:37 +0100 3210493 http://www.medworm.com/index.php?rid=3210492&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn91-article02.htm This article summarizes the presentations made at that webinar. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=3210492 Wed, 27 Jan 2010 14:29:47 +0100 3210492 http://www.medworm.com/index.php?rid=3210491&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn91-article01.htm This article reviews the results of the 'Predicting the Future of the Drug Industry: 2010 & Beyond!' survey and provides background on future trends. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=3210491 Wed, 27 Jan 2010 14:28:58 +0100 3210491 http://www.medworm.com/index.php?rid=3094722&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn810-article04.htm Building Brand Loyalty and Consumer Confidence In this guest article, Carla Stratfold, CEO at OnRequest Images, presents several key learnings and best practices that pharmas can follow when building brand and consumer loyalty (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=3094722 Wed, 16 Dec 2009 20:56:19 +0100 3094722 http://www.medworm.com/index.php?rid=3094718&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_810_UpFront.pdf Now that the FDA public hearing about regulating drug and medical device promotion on the Internet has come and gone, everyone who has a stake in the issues discussed at that hearing is wondering what the next steps are. Practically everyone believes the FDA will issue some form of guidance for the industry. Here's a list of important questions for FDA from our readers. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=3094718 Wed, 16 Dec 2009 20:56:19 +0100 3094718 http://www.medworm.com/index.php?rid=3094721&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn810-article03.htm This article presents key takeaways from the FDA hearing, a synopsis of the presentations made by John Mack, Publisher, Pharma Marketing News, at the hearing, a review of Ignite Health's study regarding effectiveness of sponsored links, and the next steps in the process of issuing guidance. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=3094721 Wed, 16 Dec 2009 20:56:14 +0100 3094721 http://www.medworm.com/index.php?rid=3094720&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn810-article02.htm What to Do While Waiting for Those Guidelines In this article, Julie Batten, eMarketing Manager at Klick Pharma discusses pharma's options for search marketing in this period between the FDA public hearing and when the much anticipated draft and final guidance on the issue is published. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=3094720 Wed, 16 Dec 2009 20:55:27 +0100 3094720 http://www.medworm.com/index.php?rid=3094719&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn810-article01.htm This article focuses on a new study that suggests drug price increases are engineered to cover the costs of Direct-to-Consumer Advertising (DTCA). Drug price trend data from AARP, AHRQ, and prescription drug consumer price index (CPI) are presented. Also, what's the link between DTCA and competition? (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=3094719 Wed, 16 Dec 2009 20:54:18 +0100 3094719 http://www.medworm.com/index.php?rid=2937095&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn89-article03.htm This article summarizes ParagonRx's ideas about how to develop a REMS that can be a win-win-win situation for you, your product, and the patient. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2937095 Thu, 29 Oct 2009 12:45:11 +0100 2937095 http://www.medworm.com/index.php?rid=2937092&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_89_UpFront.pdf John Mack, Editor of Pharma Marketing News, will make a presentation in front of the DDMAC at the November, 2009, public hearing on Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2937092 Thu, 29 Oct 2009 12:45:11 +0100 2937092 http://www.medworm.com/index.php?rid=2937094&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn89-article02.htm This article addresses that question. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2937094 Thu, 29 Oct 2009 12:43:56 +0100 2937094 http://www.medworm.com/index.php?rid=2937093&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn89-article01.htm This article presents ideas for regulatory 'safe harbors' under which pharmaceutical companies would be relieved of the responsibility of monitoring social media for adverse events. Includes a detailed summary of responses to the survey "FDA Regulation of Drug & Device Promotion via the Internet & Social Media" regarding social media adverse event monitoring, processing, challenges, and uncertainties. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2937093 Thu, 29 Oct 2009 12:43:18 +0100 2937093 http://www.medworm.com/index.php?rid=2822622&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn88-article03.htm This article summarizes the findings of a survey of over 400 of @pharmaguy's followers. The results will give you a better idea why people who are interested in the pharmaceutical industry use Twitter and what they expect to get out of it. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2822622 Tue, 22 Sep 2009 20:13:32 +0100 2822622 http://www.medworm.com/index.php?rid=2822619&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_88_UpFront.pdf The FDA is requesting the public to submit comments to a series of specific questions regarding the Promotion of Food and Drug Administration-Regulated Medical Products Using the Internet and Social Media Tools. These questions are included in a new survey created by Pharma Marketing News. Let's use this survey to help educate the FDA on the issues. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2822619 Tue, 22 Sep 2009 20:13:32 +0100 2822619 http://www.medworm.com/index.php?rid=2822621&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn88-article02.htm What the Ghosts Have to Say About It Pharma Marketing News surveyed readers to determine if medical journal articles sponsored and ghostwritten by drug companies are a legitimate part of marketing to physicians and to get opinions on various other issues raised in the press about ghostwriting. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2822621 Tue, 22 Sep 2009 20:12:50 +0100 2822621 http://www.medworm.com/index.php?rid=2822620&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn88-article01.htm Be Sure Not to Cut Off the Ends of Your Ham What If There Were No Rules in Pharma Marketing? There's no FDA, no DDMAC, no FTC. Your company guidelines and rules don't exist and your regulatory and legal teams have been disbanded. It's a free-for-all and there are no rules. The question is: what would you do? (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2822620 Tue, 22 Sep 2009 20:12:07 +0100 2822620 http://www.medworm.com/index.php?rid=2677110&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn87-article03.htm This article summaries Congressional testimony, ACCME data, and results of a reader survey on this topic. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2677110 Thu, 06 Aug 2009 14:16:52 +0100 2677110 http://www.medworm.com/index.php?rid=2677107&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_87_UpFront.pdf PR people are used to issuing press releases to a few journalists at the top of the traditional news pyramid. When the top was blown off by the social media revolution, these professionals had no proven mechanism by which to reach the many thousands of bloggers at the BOTTOM of the pyramid -- until now. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2677107 Thu, 06 Aug 2009 14:16:52 +0100 2677107 http://www.medworm.com/index.php?rid=2677109&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn87-article02.htm This article provides several summaries written by the roundtable discussion leaders themselves. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2677109 Thu, 06 Aug 2009 14:15:53 +0100 2677109 http://www.medworm.com/index.php?rid=2677108&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn87-article01.htm This article presents such a model developed by TNS Healthcare, A Kantar Health Company. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2677108 Thu, 06 Aug 2009 14:14:54 +0100 2677108 http://www.medworm.com/index.php?rid=2582587&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_86_UpFront.pdf Twitter is growing by leaps and bounds! Which makes Twitter attractive to pharmaceutical marketers. But can pharma's Twitter campaigns reach a significant number of people? Will they reach the right people? Is Twitter even appropriate for branded messages? (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2582587 Thu, 09 Jul 2009 00:59:31 +0100 2582587 http://www.medworm.com/index.php?rid=2582590&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn86-article03.htm The recent FDA Draft Guidance for Industry, Presenting Risk Information in Prescription Drug and Medical Device Promotion guidance focuses almost exclusively on print and broadcast promotional ads. It is possible, however, to apply some of FDA's "thinking" to certain kinds of Internet ads such as search engine paid ads. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2582590 Thu, 09 Jul 2009 00:59:28 +0100 2582590 http://www.medworm.com/index.php?rid=2582589&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn86-article02.htm This article summarizes the results of that survey. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2582589 Thu, 09 Jul 2009 00:58:18 +0100 2582589 http://www.medworm.com/index.php?rid=2582588&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn86-article01.htm This article focuses in some detail on three interesting pharma social media initiatives: (1) Procter & Gamble's Asacol Community for Ulcerative Colitis Patients; (2) Novo Nordisk's Levemir-branded Race With Insulin Twitter account; and (3) UCB's sponsored epilepsy community on the PatientsLikeMe website. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2582588 Thu, 09 Jul 2009 00:57:17 +0100 2582588 http://www.medworm.com/index.php?rid=2385054&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn84-article04.htm This article summarizes key presentations made at the April 21, 2009, Social Pharmer 'unconference' where leading pahram social media proponents presnted ideas on how the industry can overcome the barriers. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2385054 Thu, 30 Apr 2009 19:24:15 +0100 2385054 http://www.medworm.com/index.php?rid=2385050&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_84_UpFront.pdf The April 2009 issue of Pharma Marketing News is focused on social media, patient empowerment (which is powered by social media), and the constraints of regulation. This OpEd presents some background on social media usage and discusses how the articles in this issue are related. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2385050 Thu, 30 Apr 2009 19:24:15 +0100 2385050 http://www.medworm.com/index.php?rid=2385053&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn84-article03.htm This article summarizes the recent Digital Pharma Europe congress where it was the time right to see that European pharma marketers are also interested in new/social/digital media in pharma, but may be more constrained by regulators than their brethern in the US. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2385053 Thu, 30 Apr 2009 19:23:46 +0100 2385053 http://www.medworm.com/index.php?rid=2385052&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn84-article02.htm This article presents a case for the drug industry to adopt a patient-centric model in which pharma companies can develop unique expertise in decoding the behavior, needs, motivations of empowered patients and then use this knowledge as the basis for helping healthcare professionals and payers to put into place programs that achieve better patient outcomes. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2385052 Thu, 30 Apr 2009 19:23:04 +0100 2385052 http://www.medworm.com/index.php?rid=2385051&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn84-article01.htm A Call for a Public Hearing at FDA Shouldn't we make sure that when it comes time for the FDA to actually create a guidance document on social media that it does it with input from ALL stakeholders? Survey results. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2385051 Thu, 30 Apr 2009 19:22:10 +0100 2385051 http://www.medworm.com/index.php?rid=2313872&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn83-article04.htm This article reviews the medical privacy restrictions included in the American Recovery and Reinvestment Act, which President Obama signed into law on Feb. 17, 2009, and discusses the impact these restrictions might have on pharmaceutical marketing. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2313872 Mon, 30 Mar 2009 15:09:41 +0100 2313872 http://www.medworm.com/index.php?rid=2313868&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FPMNews_83_UpFront.pdf Many publishers, including Pharma Marketing News, and even the FDA syndicate content via RSS feeds. In this UpFront piece, John Mack, Pharma Marketing News Editor, reviews how PMN uses RSS feeds to provide content to our readers from a wide variety of sources including the FDA, PhRMA, major news media, blogs, trade publications, etc. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2313868 Mon, 30 Mar 2009 15:09:41 +0100 2313868 http://www.medworm.com/index.php?rid=2313871&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn83-article03.htm This article describes FDA's social networking initiatives in context of these questions. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2313871 Mon, 30 Mar 2009 15:09:01 +0100 2313871 http://www.medworm.com/index.php?rid=2313870&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn83-article02.htm In this article, Kim Slocum, former Director, Strategic Planning & Business Development at AstraZeneca describes several alternative future health care system scenarios and makes a case for the industry to support Comparative Effectiveness Research or CER. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2313870 Mon, 30 Mar 2009 15:08:21 +0100 2313870 http://www.medworm.com/index.php?rid=2313869&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn83-article01.htm This article summarizes the results of the "How to Earn Back the Public's Trust" survey hosted by Pharma Marketing News between February 4, 2009 and March 14, 2009 , including selected comments from respondents and other commentators. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2313869 Mon, 30 Mar 2009 15:08:06 +0100 2313869 http://www.medworm.com/index.php?rid=2235671&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn82-article04.htm This article summarizes a recent discussion between eyeforpharma's Editor Lisa Roner and Hans Nagl, Promotion Response Modelling Manager, Shire, about how the current economy and changing pharma landscape is impacting program effectiveness measures. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2235671 Tue, 03 Mar 2009 19:02:07 +0100 2235671 http://www.medworm.com/index.php?rid=2235667&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FArticle-Upfront-PMN82-Feb09.pdf Pharma Marketing News and the entire Pharma Marketing Network comprised of Web sites, blogs and social networking discussion boards pledges to help its readers, subscribers and advertisers do well during this tough time for the economy. Lower prices, less advertising, more free exposure, and different channels of communication are some of the changes we plan to implement. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2235667 Tue, 03 Mar 2009 19:02:07 +0100 2235667 http://www.medworm.com/index.php?rid=2235670&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn82-article03.htm Book Review and Insights for Pharma The pharmaceutical industry must find ways to utilize the new media tools that other industries use while ensuring compliance with FDA regulations. The good news is we can! The author summaries the content of the book and offers practical guidelines for the pharma marketers. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2235670 Tue, 03 Mar 2009 19:01:14 +0100 2235670 http://www.medworm.com/index.php?rid=2235669&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn82-article02.htm This article presents a summary of a recent TNS Healthcare webinar and personal conversations with presenters conducted beforehand. Included are NEW research results about how US and European physicians rate pharmaceutical companies against a number of customer value points that are important in achieving success with the new sales model. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2235669 Tue, 03 Mar 2009 19:00:28 +0100 2235669 http://www.medworm.com/index.php?rid=2235668&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn82-article01.htm This article is a compilation of summaries of presentations made at the 2009 ePharma Summit. Included are highlights posted to the ePharma Summit and other blogs during the conference and insights on epharma marketing issues provided by several conference speakers and attendees. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2235668 Tue, 03 Mar 2009 18:59:38 +0100 2235668 http://www.medworm.com/index.php?rid=2138895&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn81-article04.htm Stand Up for Healthcare Marketing Free Speech! So says Dmitriy Kruglyak of Trusted.MD Network who thinks PhRMA has caved in to hypocritical attacks by the media and other critics of the industry. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2138895 Wed, 28 Jan 2009 15:55:45 +0100 2138895 http://www.medworm.com/index.php?rid=2138891&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FArticle-Upfront-PMN81-Jan09.pdf Before the year is out you probably will know one or two or more people who are no longer employed in this industry. These people may have several employment options, but they may no longer be sought after by any company related to the drug industry. So, what is life like after pharma? (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2138891 Wed, 28 Jan 2009 15:55:45 +0100 2138891 http://www.medworm.com/index.php?rid=2138894&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn81-article03.htm This article outlines the major provisions of the guidance and helps you learn how to make iy work for your company. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2138894 Wed, 28 Jan 2009 15:54:35 +0100 2138894 http://www.medworm.com/index.php?rid=2138893&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn81-article02.htm Convincing Pharma Marketers to Engage in "e" An EXCLUSIVE, members-only Facebook Group through which pharmaceutical eMarketing experts 'meet' to discuss and exchange views on how to advance the use of the Internet and other technologies in pharmaceutical marketing, sales, and communications. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2138893 Wed, 28 Jan 2009 15:53:46 +0100 2138893 http://www.medworm.com/index.php?rid=2138892&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn81-article01.htm A bad economy, anemic drug pipelines, and draconian regulations -- is a perfect storm brewing? We poll readers and experts to help predict the immediate future of DTC advertising and to get some insights. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2138892 Wed, 28 Jan 2009 15:52:36 +0100 2138892 http://www.medworm.com/index.php?rid=2054707&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn710-article04.htm This article summarizes the results of a recent survey in which varioous stakeholders voted for their choice. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2054707 Thu, 18 Dec 2008 21:15:53 +0100 2054707 http://www.medworm.com/index.php?rid=2054703&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FArticle-Upfront-PMN710-Dec2008.pdf Usually, at this time of the year, editors look back on the major stories of the past year. Let’s be different and look forward to the New Year! Not that it’s going to be any more pleasant than the old year; it’s just better to prepare for what’s coming than to reminisce about what’s come and gone. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2054703 Thu, 18 Dec 2008 21:15:53 +0100 2054703 http://www.medworm.com/index.php?rid=2054706&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn710-article03.htm This article summarizes the main points Daschle makes and reveals his plan for 'fixing' the problem. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2054706 Thu, 18 Dec 2008 21:12:26 +0100 2054706 http://www.medworm.com/index.php?rid=2054705&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn710-article02.htm In a syndicated study that identifies what physicians perceive to be the top pharmaceutical PAPs in the industry, Market Strategies -- a research and strategic consulting firm -- identified how PAP image influences overall corporate image among oncology physician specialists, what performance measures drive a pharmaceutical company's PAP image, and which companies are perceived as having the best PAP. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2054705 Thu, 18 Dec 2008 20:02:51 +0100 2054705 http://www.medworm.com/index.php?rid=2054704&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn710-article01.htm The two traditional means by which pharmaceutical marketers have relied on for many, many years to encourage the uptake of new pharmaceutical products -- direct-to-consumer (DTC) advertising and physician marketing -- are about to change. Prepare now for the coming FDA and pharmaceutical marketing reforms. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=2054704 Thu, 18 Dec 2008 20:01:12 +0100 2054704 http://www.medworm.com/index.php?rid=1982186&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn79-article03.htm This article is a review of a presentation by Aaron Uydess, Senior eMarketing Manager at Novo Nordisk, made at Eye for Pharma's 3rd eCommunication and Online Marketing Summit held October 23-24, 2008, in Boston, Massachusetts. Uydess presents a best-in-class approach to developing online plans that align with strategy, reduce silos, and measure and merchandise digital strategies across a pharmaceutical marketing organization. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=1982186 Thu, 20 Nov 2008 14:44:25 +0100 1982186 http://www.medworm.com/index.php?rid=1982185&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn79-article02.htm In today's competitive market, pricing and reimbursement strategies are key to maximizing brand success and ROI. Because every country's healthcare system is different-and every product situation is unique-every brand requires a specific access plan, tailored to each market. And you must support each plan with effective messaging that ensures strong product acceptance and uptake. Experts from TNS Healthcare spoke on this issue in a recent webinar and during an exclusive interview with Pharma Marketing News. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=1982185 Thu, 20 Nov 2008 14:43:11 +0100 1982185 http://www.medworm.com/index.php?rid=1982184&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2Fpmn79-article01.htm Should free drug samples be banned? The new PhRMA Code on Interactions with Healthcare Professionals bans free pens and out-of-office lunches, but it doesn't ban samples. Many sales consider free drug samples an important marketing tactic that they can employ to gain access to physicians. In 2005, the pharmaceutical industry distributed more than $18 billion worth of drug samples. But critics are concerned that drug samples increase costs, raise questions about the appropriateness of treatment choices, and create real or perceived conflicts of interest in the medical profession. (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=1982184 Thu, 20 Nov 2008 14:42:53 +0100 1982184 http://www.medworm.com/index.php?rid=1982183&cid=s_38166_34_f&fid=38166&url=http%3A%2F%2Fwww.news.pharma-mkting.com%2FArticle-Upfront-PMN79-Nov2008.pdf There is no doubt that Dr. Andrew von Eschenbach, the current FDA Commissioner, will soon be leaving the FDA and will not allow the door to hit him on the ass on the way out. Who will Obama nominate to replace von Eschenbach? There are plenty of special interest groups that would like to influence his decision. I wonder how Obama will balance all these diverse interests to pick the right person? Whoever the nominee is, the new FDA Commissioner will also need to balance competing interests (Source: Pharma Marketing News) Pharma Marketing News info http://www.medworm.com/rss/comments.php?id=1982183 Thu, 20 Nov 2008 14:39:05 +0100 1982183